Skip to content
March 13, 2024

Equity.Guru

Investment information for the new generation

Search

VRT.C

Cannabis went crazy in 2018. Billion-dollar acquisitions by international food and beverage giants like Constellation Brands (STZ.NYSE) as well as Canada and California’s legalization of recreational marijuana drove retail investors…
Veritas Pharma (VRT.C) moved further along the trail to commercialization when the company announced that it is currently working with its research arm, Cannevert Therapeutics to design and implement…
Rapidly growing US weed player Marapharm (MDM.C) has been taking full advantage of the several million in cash they’ve brought in from warrants of late, building out a 360k…
Biotech research outfit Veritas Pharma (VRT.C), which has locked up a multitude of big academics as it seeks to lock down the best strains to deal with pain and…
First off, big welcome to any VancouverIsAwesome folk who have found their way over to our humble abode via my new weekly column Investing is Awesome. Nose around and…
Veritas Pharma (VRT.C), the medical marijuana research stock that took a two week hit as a large investor dumped his stock to market, rebounded fully today on a day…
Yesterday, I wrote a quick story about how Veritas Pharma (VRT.C) had jumped 15% or so after a mild sell-off the week before. By the time I’d posted it,…
When I was running the editorial show at Stockhouse, I had reason to look over a lot of messageboards for a wide variety of public companies. Almost without fail,…
Rolling around the junior markets this morning, there’s considerable activity among many ‘friends of Equity.guru’ such as Veritas. Veritas Pharmaceuticals (VRT.C) announced this past week it has placed its…
Last December, Canadian Liberal Party mover/shaker, founding partner in Canopy Growth Corporation (CGC.V) and private equity player Chuck Rifici bought Wikileafs, the best named dispensary price comparison app out…